ANEB-001

• UNSPSC Description:

  ANEB-001 is an orally active CB1 inhibitor, can be used to research acute cannabinoid intoxication[1].

• Target Antigen:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/aneb-001.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(C)(C)NC(N(C1)CC1O[C@H](C2=CC=C(C=C2)Cl)C3=C(C=CC=C3)C(F)(F)F)=O

• Molecular Weight:

  440.89

• References & Citations:

  [1]Joseph Fenton Lawler, et al. Formulations and methods for treating acute cannabinoid overdose. US11141404B1

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 2

• CAS Number:

  791848-71-0